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Abstract
Background Medication errors (MEs) are largely under-
reported, which undermines quality improvement and
medication risk management in healthcare.
Objectives To assess attitudes of Ugandan healthcare
professionals (HCPs) towards ME reporting, and identify
characteristics of HCPs who endorsed integration of ME
and adverse drug reaction (ADR) reporting, valued patient
involvement in ME reporting, disclosed having ever made
potentially harmful MEs, or observed possibly harmful
MEs committed by other HCPs.
Methods Healthcare professionals self-completed a
questionnaire on their attitudes towards the occurrence and
reporting of MEs in purposively selected Ugandan health
facilities (public/private) including the national referral and
six regional referral hospitals representative of all regions.
Results Response rate was 67 % (1345/2000). Most HCPs
(91 %; 1174/1289) approved a national ME reporting system
for Uganda and 58 % (734/1261) endorsed integration of ME
and ADR reporting. Two-thirds (65 %; 819/1267) of HCPs
valued patient involvement in ME reporting, one-fifth (18 %;
235/1310) disclosed that they had ever made potentially
harmful MEs, while two-fifths (41 %; 542/1323) had ever
identified possibly harmful MEs committed by other HCPs.
Endorsing patient involvement in ME reporting was more
likely by HCPs who valued root-cause analysis and reporting
of both actual and potential MEs, or who conceded inade-
quate communication and lack of time. Self-disclosure of
having ever committed potentially harmful MEs was more
likely with the need for confidentiality, working in stressful
conditions, and willingness to report ADRs. Identifying
possibly harmful MEs committed by other HCPs was more
likely by non-nurses and those who reported blame culture,
stressful conditions, ever encountered a fatal ADR, or
attachment to hospital-level health facility.
Conclusion A non-punitive healthcare environment and
patient involvement may promote ME disclosure and
reporting in Uganda and possibly other African countries.
Key Points
Most Ugandan HCPs approved the establishment of
a national ME reporting system.
Only one in five HCPs disclosed that they had ever
committed potentially harmful MEs.
Two in three HCPs valued patient involvement in
ME reporting.
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1 Introduction
Medication errors (MEs) are the commonest preventable
cause of patient harm [1] and have been associated with
increased morbidity, mortality, and healthcare costs [2, 3].
Medication errors can arise at the prescribing, dispensing,
or administration stages of the medication use process, and
may or may not have adverse consequences [4]. The scope
of pharmacovigilance (PV), defined as the science and
activities related to the detection, assessment, understand-
ing, and prevention of adverse drug reactions (ADRs) or
any other drug-related problems [5], was broadened to
incorporate the reporting of MEs [6, 7]. Through ME
reporting systems, detection and root-cause analysis of
MEs can identify individual and system weaknesses that
should be addressed to improve patient safety [8]. How-
ever, MEs are largely under-reported [9], which undermi-
nes quality improvement and risk management in
healthcare [10].
Studies conducted in the more developed countries have
observed that the success of ME reporting systems relies on
their ability to create a ‘‘no-blame-culture,’’ to encourage
confidentiality of reported information, or to provide an
option for reporter anonymity. The system should encour-
age ease of use, voluntary reporting, root-cause analysis of
reported MEs, and giving timely feedback of error analysis
results and recommendations to ME reporters [11, 12].
Fernald et al. [13] have observed that ME reporting sys-
tems that keep the identity of the reporter confidential
receive higher quality ME reports when compared with
anonymous ME reporting systems where the reporter does
not reveal his/her identity. Furthermore, reporter anonym-
ity has been reported to make follow-up difficult [14].
Healthcare professionals (HCPs) are a lynchpin in the
effective functioning of ME reporting systems [12], both as
a key source of ME reports and as users of the information
arising from the analysis of these ME reports. In addition to
promoting transparency and safe medication practices by
HCPs, involving patients in their care is a crucial facet in
promoting a safety culture in healthcare [15].
Globally, the World Health Organization–Uppsala
Monitoring Centre (WHO–UMC) operates an international
database, Vigibase, which receives spontaneous suspected
adverse reaction reports from National Pharmacovigilance
Centres (NPCs) from over 80 countries [16]. The database
contained over 10 million reports by April 2015 and the
oldest reports date back as early as 1968 [17]. The USA
Institute for Safe Medication Practices, established over
35 years ago, is a voluntary ME reporting system for HCPs
which can be accessed through an online platform [18].
Similarly, the European Medicines Agency (EMA), which
started in 1995, operates a web-based system (Eudravigi-
lance) to monitor medication safety reports within the
European Union (EU). Eudravigilance was established in
2001 and has since 2012 been empowered by EU legisla-
tion to receive information on ADRs resulting from MEs
[19].
In African countries, ME reporting systems have
hardly been embraced [20]. However, even when their
establishment is scaled up, both existing and new ME
reporting systems face the challenge of inherent weak-
nesses in African healthcare systems including but not
limited to counterfeit and substandard medicines,
unavailability of fundamental infrastructure, shortage of
human resources for health, limited awareness or interest
of HCPs in PV activities, weak medicines regulatory and
PV systems, and scarce financial resources [7, 21].
Information is scarce on involvement of African HCPs in
voluntary ME reporting systems, including HCPs’
expectations of these reporting systems, and the likely
disclosure of harmful MEs made either in person or by
their colleagues. However, findings from medical audits
conducted in Africa suggest that the extent of ME
occurrence in these settings might even be a bigger
problem than suspected ADRs, and that ME detection and
prevention may be possible [22–24].
Uganda’s NPC is yet to establish a formal ME reporting
and evaluation system. A functional spontaneous ADR
reporting system has been operational since 2005 with 14
regional pharmacovigilance centres [25, 26]. The Ugandan
NPC’s mandate has been extended to integrate ME
reporting [27]. However, data on HCPs’ readiness, their
attitudes to, and characteristics associated with ME
reporting in our resource-limited setting are lacking.
We assessed the attitudes and the personal and profes-
sional characteristics of Ugandan HCPs related to inte-
gration of ME and ADR reporting systems, patient
involvement in ME reporting, and disclosure of having
made potentially harmful MEs either in person or by other
HCP colleagues.
2 Methods
2.1 Study Design and Sampling Procedure
From May 2012 to February 2013, HCPs anonymously
self-completed a survey questionnaire on their attitudes
towards the occurrence and reporting of MEs in purpo-
sively selected geographically representative public and
private health facilities in Uganda. These facilities included
the national referral hospital, six regional referral and
district hospitals, health centres II to IV, and private health
facilities within the catchment areas of the regional referral
hospitals [26]. Eligible HCPs included those involved in
the prescribing, transcribing, dispensing, and
274 R. Kiguba et al.
administration of medications to patients. Trained research
assistants obtained separately held written informed con-
sent from the HCPs before inviting them to complete a self-
administered questionnaire. The questionnaires did not
capture respondent HCPs’ identities but were tracked using
serial numbers. Sampling frames (staff lists) in each
selected health facility were not easily obtainable, therefore
probability sampling of HCPs was not achieved. In addi-
tion, several contacts were made with willing but usually
busy HCPs and delays to return completed questionnaires
by those who accepted the invitation were common. Thus
neither the refusal rate of invited HCPs nor the return rate
of completed questionnaires by cadre were reliably recor-
ded [26].
2.2 Data Collection and Management
The self-administered questionnaire elicited demographic
and professional information, and attitudes of HCPs
towards the occurrence and reporting of MEs in Uganda.
Attitudes were measured using five items of a categorical
nature (yes/no), and 17 statements on a five-point Likert
scale with the categories: strongly disagree, slightly dis-
agree, neutral, slightly agree, and strongly agree (see ESM
Appendix).
All data were entered into a databank using EpiData 3.1.
2.3 Statistical Analysis
Questionnaire responses were summarized as frequencies
and percentages.
We used Principal Components Analysis (PCA) and
Exploratory Factor Analysis (EFA) techniques on the 22
variables primarily to identify and combine or drop mul-
ticollinear variables that would affect subsequent regres-
sion analyses. The data reduction PCA technique was
employed to identify and combine redundant (highly cor-
related) variables into fewer uncorrelated components, of
which none were identified. The structure detection EFA
technique was used, in addition, to determine if there were
underlying latent relationships between the variables on
attitudes to ME reporting. However, EFA did not suc-
cessfully extract any factor solution(s) that adequately
represented sets of individual variables. Thus, individual
variables were retained in subsequent regression analyses.
Likert scales were dichotomized into agree or other
(disagree and neutral). We used binary logistic regression
to assess demographic, professional, and attitudinal factors
associated with four key variables, namely: ‘‘Integration of
the ME and ADR reporting systems’’, ‘‘Patient participa-
tion in the reporting of MEs’’, ‘‘Disclosure by a respondent
HCP that they had ever committed MEs that had the
potential to harm patients’’, and ‘‘Having ever seen other
HCPs commit MEs that had the potential to harm
patients’’.
Variables that were logically thought to measure similar
constructs were not simultaneously fitted into the same
regression models due to their inevitably high correlation.
The following four variables were thought to measure
similar fundamental facets of ME reporting: ‘‘Establish-
ment of a national system for reporting Medication Errors
(MEs)’’, ‘‘Integration of the ME and Adverse Drug Reac-
tion (ADR) reporting systems’’, ‘‘Mandatory or voluntary
reporting of MEs’’, and ‘‘Patient participation in ME
reporting’’. Other pairs of variables thought to measure
similar constructs were: ‘‘Having seen others commit
medication errors that had the potential to harm patients’’
and ‘‘Having committed medication errors that had the
potential to harm patients’’; ‘‘Disruptions in continuity of
patient care, such as shift changes, can be detrimental to
patient care’’ and ‘‘Important issues are well communicated
at shift changes’’; ‘‘Personal details of the person who
made an error should be reported’’ and ‘‘I may hesitate to
use a reporting system for MEs because I am concerned
about being identified’’; and ‘‘I would recommend a non-
disciplinary approach to encourage HCPs to report MEs’’
and ‘‘There is a culture of blame in healthcare’’.
Regression coefficients were expressed as odds ratios
(ORs) with their 95 % confidence intervals (CIs) and were
obtained using Stata 12.0 [28]. To take account of the
multiplicity of potential covariates, we focused attention
only on influential factors for which P\ 0.01. We
accounted for missing data using the missing-assigned
approach where low-frequency missing data were mean-
ingfully assigned to an existing category [26].
3 Results
3.1 Study Population
A total of 1345 HCPs self-completed the questionnaire,
representing a response rate of 67 % (n = 2000). Mean age
of HCPs was 32.4 years (SD = 8.9) and females were the
majority (60 %; 804/1345). About three-fifths (58 %;
156/271; n = 275) of doctors reported that they had given
verbal prescriptions to attending nurses in the previous
year, and 54 % (376/693; n = 792) of nurses stated that
they regularly transcribed prescriptions.
3.2 Attitudes to the Reporting of Medication Errors
(MEs)
Most of the surveyed HCPs (91 %; 1174/1289) agreed that
Uganda should have a national ME reporting system, 58 %
(734/1261) agreed that the ME reporting system should be
Medication Error Disclosure and Reporting by Ugandan Healthcare Professionals 275
integrated into the ADR reporting system, and 65 % (819/
1267) stated that patients should participate in ME
reporting (see Table 1).
Eighty-five percent (1125/1326) of HCPs agreed that
reported MEs should be used to find the root causes of the
MEs, while organizational leadership and support were
needed in ME reporting according to 82 % (1081/1324) of
respondent HCPs. Sixty-two percent (806/1308) of HCPs
believed that there is a culture of blame within the
healthcare system, with 33 % (436/1315) reporting that
they would hesitate to use a ME reporting system due to
concerns about being identified, and 31 % (412/1328)
agreeing that personal details of the person who made an
error should be reported (see Table 1).
3.3 Disclosure of MEs
Eighteen percent (235/1310) of HCPs disclosed that they
had ever made MEs that had the potential to harm
patients, while 41 % (542/1323) acknowledged that they
had ever identified potentially harmful MEs that were
committed by other HCPs (see Table 1) (v2 = 64.7
(1 df), P\ 0.001). Forty-seven percent (623/1327) of the
HCPs had either disclosed that they had committed, in
person, potentially harmful MEs or had witnessed the
involvement of other HCPs. Thirty-nine percent (519/
1315) of HCPs agreed that they were more likely to
make MEs in tense or hostile (stressful) working con-
ditions (see Table 1).
Table 1 Attitudes to medication error (ME) reporting by healthcare professionals, Uganda, 2013
Variablea Yes, n (%) No, n (%)
Establishment of a national ME reporting system 1174 (91.1) 115 (8.9)
Integration of the ME and ADR reporting systems 734 (58.2) 527 (41.8)
Focus on fatal adverse events 312 (24.4) 965 (75.6)
Patient participation in ME reporting 819 (64.6) 448 (35.4)
Mandatory ME reporting system 946 (73.8) 336 (26.2)
Statementa Agree, n (%) Neutral, n (%) Disagree, n (%)
Reported MEs should be used to find the root causes of the MEs 1125 (84.8) 95 (7.2) 106 (8.0)
I would recommend a non-disciplinary approach to encourage ME reporting 917 (69.2) 191 (14.4) 218 (16.4)
There is lack of time for reporting MEs 336 (25.4) 208 (15.8) 777 (58.8)
There is a culture of blame within healthcare 806 (61.6) 216 (16.5) 286 (21.9)
There is a need for organizational leadership and support in reporting MEs 1081 (81.7) 133 (10.0) 110 (8.3)
Personal details of the person who made an error should be reported 412 (31.0) 221 (16.7) 695 (52.3)
The system should report both actual and potential MEs 907 (69.1) 220 (16.8) 185 (14.1)
Medication errors are handled appropriately in this setting 676 (51.8) 242 (18.5) 387 (29.7)
The culture in this health facility makes it easy to learn from the MEs of others 722 (54.6) 246 (18.6) 354 (26.8)
I am more likely to make MEs in tense or hostile situations 519 (39.5) 197 (14.9) 599 (45.6)
I have seen others make MEs that had the potential to harm patients 542 (41.0) 203 (15.3) 578 (43.7)
Disruptions in continuity of patient care can be detrimental to patient safety 678 (52.0) 235 (18.0) 391 (30.0)
I have made MEs that had the potential to harm patients 235 (17.9) 171 (13.1) 904 (69.0)
Important issues are well communicated at shift changes 868 (67.1) 187 (14.5) 238 (18.4)
I may hesitate to report MEs due to concerns about being identified 436 (33.2) 234 (17.8) 645 (49.0)
I should be financially rewarded for reporting MEs 348 (26.3) 244 (18.4) 732 (55.3)
Minor medication errors should not be reported 371 (28.0) 154 (11.6) 801 (60.4)
ADR adverse drug reaction
a Variables have missing data
276 R. Kiguba et al.
3.4 Characteristics of Healthcare Professionals
(HCPs) Who Endorsed Integration of the ME
and Adverse Drug Reaction (ADR) Reporting
Systems
Older HCPs [at least 30 years old (OR = 1.5; 95 % CI:
1.15–1.87)] or those who had made suggestions on how
to improve the ADR reporting system (OR = 1.5; 95 %
CI: 1.11–1.93) were more likely to endorse integration of
the ME and ADR reporting systems. However, integra-
tion was less likely to be promoted by non-nurses
(OR = 0.5; 95 % CI: 0.39–0.65) and HCPs who had
ever encountered a fatal ADR (OR = 0.6; 95 % CI:
0.43–0.80) (see Table 2).
3.5 Characteristics of HCPs Who Endorsed Patient
Participation in ME Reporting
Healthcare professionals who valued root-cause analysis of
reported MEs (OR = 1.6; 95 % CI: 1.11–2.18), those who
reported inadequate communication at shift changes
(OR = 1.4; 95 % CI: 1.10–1.87), or who agreed that both
actual and potential MEs should be reported (OR = 1.4;
95 % CI: 1.10–1.88), and those who conceded that there is
lack of time for reporting MEs (OR = 1.5; 95 % CI:
1.12–2.00) were more likely to endorse patient participa-
tion in ME reporting (see Table 3).
3.6 Characteristics of HCPs Who Disclosed
that They had Ever Committed Potentially
Harmful MEs
The need for confidentiality (OR = 1.6; 95 % CI:
1.14–2.14) and working in stressful conditions (OR = 2.0;
95 % CI: 1.47–2.77) were the characteristics of HCPs more
likely to disclose that they had ever committed potentially
harmful MEs. However, self-disclosure of MEs was less
likely from HCPs who agreed that both actual and potential
MEs should be reported (OR = 0.6; 95 % CI: 0.44–0.85)
or those who were hesitant to report ADRs (OR = 0.6;
95 % CI: 0.47–0.87) (see Table 4).
3.7 Characteristics of HCPs Who Ever Identified
Potentially Harmful MEs Committed by Other
HCPs
Attachment to a hospital-level health facility (OR = 1.7;
95 % CI: 1.23–2.30), reporting that there is a culture of
blame in healthcare (OR = 1.6; 95 % CI: 1.28–2.11) or
working in stressful conditions (OR = 1.4; 95 % CI:
1.12–1.84); and being a non-nurse (OR = 1.5; 95 % CI:
1.15–1.92) or having ever encountered a fatal ADR
(OR = 1.5; 95 % CI: 1.13–2.05) were associated with
having ever identified potentially harmful MEs committed
by other HCPs (see Table 5).
4 Discussion
Nine in ten HCPs agreed that Uganda should have a
national ME reporting system, suggesting their willingness
to embrace this reporting system. However, eight in ten
HCPs reported the need for organizational leadership and
support in ME reporting, a systems approach that would
likely enhance their readiness to report MEs [29]. Uganda
is yet to establish a formal ME reporting system, though a
well established spontaneous ADR reporting system,
coordinated by the NPC, has existed since 2005 [25, 26].
Despite the HCPs’ optimism for the establishment of a
national ME reporting system, the national statistics for
voluntary ADR reporting indicate that only 0.44 % of
Ugandan HCPs report suspected ADRs annually [26].
Therefore ME under-reporting by HCPs might still be a
major challenge. Moreover, voluntary ME and ADR under-
reporting continue to be a healthcare system challenge
worldwide [30, 31]. However, voluntary ME and ADR
reporting systems are still a cornerstone to medication
safety programs globally [30, 32].
Three in five HCPs agreed that the ME reporting system
should be integrated with the ADR reporting system.
Holmstrom et al. [20] identified Zambia as an example of
an African country that operates an integrated national ME
and ADR reporting system. Rwanda was another African
country with a local ME reporting system but whose setting
was not clearly defined [20]. The integration of ME and
ADR reporting could save the resources otherwise needed
to maintain separate systems, but might potentially com-
promise the quality of reporting [33] and overwhelm the
existing voluntary ADR reporting system [26] in our
resource-limited setting. Bencheikh et al. [34] have sug-
gested that pharmacovigilance centers, poison control
centers, and patient safety organizations may operate
independently but work closely together with regulatory
bodies to promote patient safety while avoiding duplicity
of functions.
The study also identified the characteristics of HCPs
who endorsed integration of the ME and ADR reporting
systems. Older HCPs and those who suggested ways to
improve the ADR reporting system were more likely to
support integration of the ME and ADR reporting systems,
and these two categories of HCPs were previously found to
be ardent ADR reporters [26]. Non-nurses (doctors, phar-
macists, pharmacy technicians, clinical officers, and oth-
ers), however, were less likely to support the integration of
the two reporting systems. Kiguba et al. [26] have reported
that in Uganda non-nurses are more likely than nurses to
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Table 2 Characteristics of 1261a healthcare professionals (HCPs) who endorsed integration of medication error (ME) reporting into the existing
adverse drug reaction (ADR) reporting system, Uganda, 2013
Factor Endorsed integration of ADR
and ME reporting
Crude analysis Adjusted analysis
Yes (%) No (%) OR 95 % CI P value OR 95 % CI P value
Level of health facility
Other 264 (57.3) 197 (42.7) 1.0 1.0
Hospital 470 (58.8) 330 (41.2) 1.1 0.84–1.34 0.607 1.2 0.85–1.61 0.333
Type of health facility
Public 318 (58.0) 230 (42.0) 1.0 1.0
Private not-for-profit 158 (60.5) 103 (39.5) 1.1 0.82–1.50 0.498 1.2 0.85–1.63 0.333
Private for-profit 258 (57.1) 194 (42.9) 1.0 0.75–1.24 0.762 1.1 0.78–1.51 0.628
Region of the country
Central 343 (58.4) 244 (41.6) 1.0 1.0
Eastern 212 (54.1) 180 (45.9) 0.8 0.65–1.08 0.178 0.7 0.52–0.98 0.038
Other 179 (63.5) 103 (36.5) 1.2 0.92–1.66 0.156 1.2 0.87–1.67 0.261
Professional cadre
Nurse 461 (63.4) 266 (36.6) 1.0 1.0
Non-nurse 273 (51.1) 261 (48.9) 0.6 0.48–0.76 \0.001 0.5 0.39–0.65 \0.001
Age (years)
Less than 30 295 (53.4) 257 (46.6) 1.0 1.0
30 or more 439 (61.9) 270 (38.1) 1.4 1.13–1.78 0.002 1.5 1.15–1.87 0.002
Department
Medicine 351 (56.9) 266 (43.1) 1.0
Surgery 57 (60.0) 38 (40.0) 1.1 0.73–1.77 0.568 1.0 0.62–1.63 0.980
Pediatrics, obstetrics and gynecology 115 (59.9) 77 (40.1) 1.1 0.81–1.57 0.462 1.1 0.76–1.56 0.637
Other 211 (59.1) 146 (40.9) 1.1 0.84–1.43 0.500 1.1 0.85–1.51 0.398
Patient load
More than 30/day 353 (63.0) 207 (37.0) 1.0 1.0
At most 30/day 381 (54.4) 320 (45.6) 0.7 0.56–0.88 0.002 0.8 0.60–0.98 0.036
Involved in medical research
No 510 (57.2) 381 (42.8) 1.0 1.0
Yes 224 (60.5) 146 (39.5) 1.1 0.90–1.47 0.279 1.3 1.00–1.69 0.054
Ever encountered fatal ADR
No 611 (60.7) 396 (39.3) 1.0 1.0
Yes 123 (48.4) 131 (51.6) 0.6 0.46–0.80 \0.001 0.6 0.43–0.80 0.001
Knows to whom to report ADRs
No 371 (59.6) 252 (40.4) 1.0 1.0
Yes 363 (56.9) 275 (43.1) 0.9 0.72–1.12 0.339 0.8 0.62–1.01 0.055
Suggested ways to improve ADR reporting
No 160 (51.6) 150 (48.4) 1.0 1.0
Yes 574 (60.4) 377 (39.6) 1.4 1.10–1.85 0.007 1.5 1.11–1.93 0.007
I would only report an ADR if I was sure that it was related to the use of a particular drug
Other 268 (56.5) 206 (43.5) 1.0 1.0
Agree 466 (59.2) 321 (40.8) 1.1 0.89–1.41 0.352 1.1 0.87–1.43 0.375
I do not know how the information reported in an ADR form is used
Other 407 (58.5) 289 (41.5) 1.0 1.0
Agree 327 (57.9) 238 (42.1) 1.0 0.78–1.22 0.830 0.9 0.71–1.14 0.381
Root-cause analysis of MEs
Other 96 (52.5) 87 (47.5) 1.0 1.0
Agree 638 (59.2) 440 (40.8) 1.3 0.96–1.80 0.089 1.2 0.83–1.66 0.375
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recognize suspect ADRs, although no significant difference
has been observed in ADR-reporting rates between the two
HCP cadre-levels. The reasons for the lower than expected
ADR reporting rate by non-nurses when compared with
nurses might partly explain the observed lower likelihood
of non-nurses to support integration of the ME and ADR
reporting systems. Sarvadikar et al. [35] and Milch et al.
[36] reported varying attitudes to ME reporting among
different cadres of HCPs in the USA, with higher reporting
rates being registered by nurses than by doctors. The nurse-
cadre-targeted adverse event training campaigns conducted
in the USA setting could explain the higher enthusiasm by
the American nurses to report MEs, and highlights the
benefits of training programmes [36]. However, in Uganda
more investigations are needed to identify the reasons why
Ugandan non-nurses, when compared with nurses, seem to
have less enthusiasm for pharmacovigilance. HCPs who
had ever encountered fatal ADRs did not favor integration
of the ME and ADR reporting systems, probably for fear of
litigation or punishment if reported fatal ADRs were linked
to reported MEs committed by these HCPs [8]. Conducting
multiple health facility-based interventions including sen-
sitization and training campaigns that target all Ugandan
HCP-cadres could be beneficial. The interventions should
address the needs of non-nurses and younger HCPs. In
addition, a non-punitive organizational-level approach such
as confidential ME reporting should be adopted.
Our research team drafted a ward-based ME reporting
form and a tracking log that will be tested in a longitudinal
study on hospitalized patients, in conjunction with a
modified ward-tailored ADR reporting form developed for
the same study [26].
Three-fifths of HCPs agreed that patients should par-
ticipate in ME reporting. This is a laudable proportion of
HCPs in support of the drive by the WHO World Alliance
for Patient Safety to increase patient involvement in the
promotion of a safety culture in healthcare [37]. Moreover,
the first African regional patients for patient safety work-
shop was held in Uganda in 2011; this brought together
patients, HCPs, and healthcare policy makers to share
experiences of harm in healthcare [38]. Lack of time for
ME reporting and inadequate communication, for instance
at shift changes, were identified characteristics of HCPs
who promoted patient participation in ME reporting. Pos-
sible explanations advanced for lack of time to report MEs
include absence of perceived benefit, the extra burden
Table 2 continued
Factor Endorsed integration of ADR
and ME reporting
Crude analysis Adjusted analysis
Yes (%) No (%) OR 95 % CI P value OR 95 % CI P value
There is a lack of time for reporting MEs
No 544 (57.1) 409 (42.9) 1.0 1.0
Yes 190 (61.7) 118 (38.3) 1.2 0.93–1.57 0.155 1.2 0.90–1.58 0.210
Need for organizational leadership and support in reporting MEs
Other 117 (51.8) 109 (48.2) 1.0 1.0
Agree 617 (59.6) 418 (40.4) 1.4 1.03–1.84 0.031 1.3 0.91–1.77 0.163
Personal details of the person who made a ME are to be reported
Other 491 (56.0) 386 (44.0) 1.0 1.0
Agree 243 (63.3) 141 (36.7) 1.4 1.06–1.73 0.016 1.2 0.93–1.58 0.157
System should report both actual and potential MEs
Other 207 (52.8) 185 (47.2) 1.0 1.0
Agree 527 (60.6) 342 (39.4) 1.4 1.08–1.75 0.009 1.2 0.93–1.58 0.160
I have made MEs that had the potential to harm patients
Other 606 (58.1) 438 (41.9) 1.0 1.0
Agree 128 (59.0) 89 (41.0) 1.0 0.77–1.40 0.798 1.1 0.82–1.54 0.464
Important issues are well communicated at shift changes
Other 244 (55.2) 198 (44.8) 1.0 1.0
Agree 490 (59.8) 329 (40.2) 1.2 0.96–1.53 0.112 1.0 0.76–1.26 0.863
I should be financially rewarded for reporting MEs
Other 546 (58.2) 393 (41.8) 1.0 1.0
Agree 188 (58.4) 134 (41.6) 1.0 0.78–1.31 0.940 1.0 0.74–1.28 0.854
a The missing-assigned approach (missing data assigned to the ‘‘no’’ category) was used to account for missing data prior to commencing the
model fitting procedures
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Table 3 Characteristics of 1267a healthcare professionals (HCPs) who endorsed patient participation in medication error (ME) reporting,
Uganda, 2013
Factor Patient participation in ME reporting Crude analysis Adjusted analysis
Yes (%) No (%) OR 95 % CI P value OR 95 % CI P value
Level of health facility
Other 281 (61.5) 176 (38.5) 1.0 1.0
Hospital 538 (66.4) 272 (33.6) 1.2 0.98–1.57 0.078 1.2 0.90–1.71 0.181
Type of health facility
Public 353 (64.4) 195 (35.6) 1.0 1.0
Private not-for-profit 177 (65.8) 92 (34.2) 1.1 0.78–1.44 0.697 1.2 0.84–1.62 0.367
Private for-profit 289 (64.2) 161 (35.8) 1.0 0.76–1.29 0.949 1.3 0.95–1.87 0.095
Region of the country
Central 410 (68.6) 188 (31.4) 1.0 1.0
Eastern 234 (59.9) 157 (40.1) 0.7 0.52–0.89 0.005 0.7 0.51–0.96 0.027
Other 175 (63.0) 103 (37.0) 0.8 0.58–1.05 0.101 0.8 0.60–1.15 0.268
Professional cadre
Nurse 463 (63.5) 266 (36.5) 1.0 1.0
Non-nurse 356 (66.2) 182 (33.8) 1.1 0.89–1.42 0.328 1.0 0.73–1.25 0.747
Age (years)
Less than 30 354 (62.5) 212 (37.5) 1.0 1.0
30 or more 465 (66.3) 236 (33.7) 1.2 0.94–1.49 0.161 1.2 0.91–1.50 0.227
Department
Medicine 393 (64.0) 221 (36.0) 1.0
Surgery 64 (68.8) 29 (31.2) 1.2 0.78–1.98 0.366 1.1 0.67–1.90 0.606
Pediatrics, obstetrics and gynecology 129 (65.2) 69 (34.8) 1.1 0.75–1.47 0.770 1.0 0.69–1.42 0.942
Other 233 (64.4) 129 (35.6) 1.0 0.77–1.33 0.910 1.0 0.72–1.28 0.777
Patient load
More than 30/day 362 (64.8) 197 (35.2) 1.0 1.0
At most 30/day 457 (64.6) 251 (35.4) 1.0 0.79–1.25 0.938 1.0 0.79–1.31 0.877
Involved in medical research
No 574 (64.4) 318 (35.6) 1.0 1.0
Yes 245 (65.3) 130 (34.7) 1.0 0.81–1.34 0.738 1.0 0.74–1.26 0.782
Ever encountered fatal ADR
No 643 (63.7) 367 (36.3) 1.0 1.0
Yes 176 (68.5) 81 (31.5) 1.2 0.93–1.66 0.150 1.1 0.78–1.48 0.647
Knows to whom to report ADRs
No 400 (64.5) 220 (35.5) 1.0 1.0
Yes 419 (64.8) 228 (35.2) 1.0 0.80–1.27 0.928 1.1 0.83–1.37 0.607
Suggested ways to improve ADR reporting
No 191 (61.0) 122 (39.0) 1.0 1.0
Yes 628 (65.8) 326 (34.2) 1.2 0.95–1.60 0.123 1.1 0.85–1.50 0.391
I would only report an ADR if I was sure that it was related to the use of a particular drug
Other 312 (65.1) 167 (34.9) 1.0 1.0
Agree 507 (64.3) 281 (35.7) 1.0 0.76–1.23 0.774 1.0 0.75–1.23 0.747
I do not know how information reported in an ADR form is used
Other 457 (65.0) 246 (35.0) 1.0 1.0
Agree 362 (64.2) 202 (35.8) 1.0 0.77–1.22 0.761 0.9 0.71–1.20 0.449
Root-cause analysis of MEs
Other 100 (52.6) 90 (47.4) 1.0 1.0
Agree 719 (66.8) 358 (33.2) 1.8 1.32–2.47 \0.001 1.6 1.11–2.18 0.011
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associated with reporting, lack of clarity on what to report,
and severity of illness [39]. Fernald et al. [13] found that
71 % of the MEs in their setting were attributed to com-
munication problems. Patients may help to bridge the
communication gaps that arise in healthcare, especially at
shift changes. However, patient-related factors such as lack
of confidence or inadequate medical knowledge are
potential barriers to their involvement in ME reporting
[37]. That notwithstanding, Weingart et al. [40] demon-
strated that patients identified adverse events that were
unaccounted for in the medical records and/or were not
covered in the hospital incident reporting system [40].
Valuing root-cause analysis and reporting of both actual
and potential MEs were the other characteristics of HCPs
more likely to promote patient participation in ME
reporting. Ugandan health facilities should institute regular
audits of medication use by patients to identify MEs.
Harmful and potentially harmful MEs identified in the
audits should be subjected to root-cause analysis [41]. The
learning derived from root-cause analysis of both harmful
and apparently minor MEs or near misses can foster system
improvements and reduce the risks associated with
healthcare [14, 32]. In our planned cohort study, incident
MEs among hospitalized patients will be assessed using
root-cause analysis. We shall involve patients to obtain
insight into their medication use experiences while in
hospital.
One in five HCPs disclosed that they had committed
potentially harmful MEs, while two in five reported that
they had seen other HCPs make MEs that had the potential
to harm patients. About half (47 %; 623/1327) of HCPs
had either disclosed that they had ever committed poten-
tially harmful MEs in person or had witnessed the
involvement of other HCPs. Similar rates of ME disclosure
by African HCPs have been reported in anesthesia practice
in Nigeria (56 %; 24/43) [42] and in South Africa (39 %;
33/84) [43]. The willingness of HCPs in our setting to
disclose both harmful and potentially harmful MEs merits
further investigation. Currently, there is no protective leg-
islation for reporting MEs in Uganda. Recognizing that a
ME has occurred, irrespective of who is involved, is a first
step in the ME reporting process. However, protective
legislation for ME reporters if instituted may likely allay
their fears of punitive action and promote ME reporting.
Table 3 continued
Factor Patient participation in ME reporting Crude analysis Adjusted analysis
Yes (%) No (%) OR 95 % CI P value OR 95 % CI P value
There is a lack of time for reporting MEs
No 600 (62.6) 358 (37.4) 1.0 1.0
Yes 219 (70.9) 90 (29.1) 1.5 1.10–1.92 0.009 1.5 1.12–2.00 0.007
Need for organizational leadership and support in reporting MEs
Other 123 (53.3) 108 (46.8) 1.0 1.0
Agree 696 (67.2) 340 (32.8) 1.8 1.35–2.40 \0.001 1.4 1.02–1.97 0.038
Personal details of the person who made a ME are to be reported
Other 548 (62.1) 334 (37.9) 1.0 1.0
Agree 271 (70.4) 114 (29.6) 1.4 1.12–1.87 0.005 1.4 1.03–1.78 0.033
System should report both actual and potential MEs
Other 222 (56.4) 172 (43.6) 1.0 1.0
Agree 597 (68.4) 276 (31.6) 1.7 1.31–2.14 \0.001 1.4 1.10–1.88 0.008
I have made MEs that could harm patients
Other 667 (63.5) 384 (36.5) 1.0 1.0
Agree 152 (70.4) 64 (29.6) 1.4 0.99–1.88 0.054 1.3 0.94–1.84 0.107
Important issues are not well communicated at shift changes
Other 517 (62.8) 306 (37.2) 1.0 1.0
Agree 302 (68.0) 142 (32.0) 1.3 0.99–1.61 0.065 1.4 1.10–1.87 0.009
I should be financially rewarded for reporting MEs
Other 623 (65.9) 322 (34.1) 1.0 1.0
Agree 196 (60.9) 126 (39.1) 0.8 0.62–1.04 0.102 0.7 0.55–0.96 0.025
ADR adverse drug reaction
a The missing-assigned approach (missing data assigned to the ‘‘no’’ category) was used to account for missing data prior to commencing the
model fitting procedures
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Table 4 Characteristics of 1310a healthcare professional (HCPs) who disclosed that they had ever committed potentially harmful medication
errors (MEs), Uganda, 2013
Factor Ever made MEs with potential to
harm patients
Crude analysis Adjusted analysis
Agree (%) Other (%) OR 95 % CI P value OR 95 % CI P value
Level of health facility
Other 90 (18.4) 400 (81.6) 1.0 1.0
Hospital 145 (17.7) 675 (82.3) 1.0 0.71–1.28 0.755 0.7 0.48–1.08 0.109
Type of health facility
Public 115 (20.7) 442 (79.3) 1.0 1.0
Private not-for-profit 42 (15.4) 230 (84.6) 0.7 0.48–1.03 0.073 0.8 0.51–1.18 0.235
Private for-profit 78 (16.2) 403 (83.8) 0.7 0.54–1.02 0.068 0.8 0.51–1.17 0.218
Region of the country
Central 117 (19.6) 481 (80.4) 1.0 1.0
Eastern 66 (16.2) 342 (83.8) 0.8 0.57–1.11 0.172 1.0 0.69–1.56 0.866
Other 52 (17.1) 252 (82.9) 0.8 0.59–1.22 0.371 1.0 0.66–1.50 0.979
Professional cadre
Nurse 124 (16.2) 644 (83.8) 1.0 1.0
Non-nurse 111 (20.5) 431 (79.5) 1.3 1.01–1.78 0.044 1.1 0.76–1.47 0.750
Age, years
Less than 30 108 (18.7) 469 (81.3) 1.0 1.0
30 or more 127 (17.3) 606 (82.7) 0.9 0.69–1.21 0.515 0.8 0.62–1.14 0.277
Department
Medicine 123 (19.3) 516 (80.7) 1.0
Surgery 19 (18.6) 83 (81.4) 1.0 0.56–1.64 0.882 0.9 0.53–1.70 0.859
Pediatrics, obstetrics and gynecology 34 (17.1) 165 (82.9) 0.9 0.57–1.31 0.495 0.9 0.59–1.48 0.778
Other 59 (16.0) 311 (84.0) 0.8 0.57–1.12 0.189 0.8 0.59–1.23 0.386
Patient load
More than 30/day 112 (19.0) 477 (81.0) 1.0 1.0
At most 30/day 123 (17.1) 598 (82.9) 0.9 0.66–1.16 0.359 0.9 0.65–1.20 0.421
Involved in medical research
No 153 (16.5) 773 (83.5) 1.0 1.0
Yes 82 (21.4) 302 (78.6) 1.4 1.02–1.85 0.039 1.2 0.88–1.68 0.231
Ever encountered fatal ADR
No 172 (16.4) 879 (83.6) 1.0 1.0
Yes 63 (24.3) 196 (75.7) 1.6 1.18–2.28 0.003 1.6 1.10–2.28 0.014
Knows to whom to report ADRs
No 136 (20.8) 519 (79.2) 1.0 1.0
Yes 99 (15.1) 556 (84.9) 0.7 0.51–0.90 0.008 0.8 0.55–1.03 0.074
Suggested ways to improve ADR reporting
No 53 (16.1) 276 (83.9) 1.0 1.0
Yes 182 (18.6) 799 (81.4) 1.2 0.85–1.66 0.318 1.3 0.88–1.80 0.206
I would only report an ADR if I was sure that it was related to the use of a particular drug
Other 110 (22.2) 385 (77.8) 1.0 1.0
Agree 125 (15.3) 690 (84.7) 0.6 0.48–0.84 0.002 0.6 0.47–0.87 0.004
I do not know how information reported in an ADR form is used
Other 125 (17.1) 605 (82.9) 1.0 1.0
Agree 110 (19.0) 470 (81.0) 1.1 0.85–1.50 0.388 1.1 0.81–1.48 0.556
Root-cause analysis of MEs
Other 41 (20.5) 159 (79.5) 1.0 1.0
Agree 194 (17.5) 916 (82.5) 0.8 0.56–1.20 0.306 0.8 0.54–1.25 0.353
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Three-fifths of doctors reported that they gave verbal
prescriptions to nurses and more than half of nurses
reported that they regularly transcribed prescriptions (a
responsibility for doctors and pharmacists in Uganda).
Thus, more opportunities for MEs may arise from doctors’
verbal prescriptions and from nurse-transcriptions. There-
fore both practices ought to be discouraged.
HCPs who preferred confidential ME reporting and
those who agreed that they had a higher likelihood to
commit MEs in stressful situations were more likely to
disclose that they had previously committed potentially
harmful MEs. A highly stressful work environment for
HCPs can arise from emergency situations and low staffing
levels, thus leading to excessive workloads and fatigue,
among others, all of which may promote error-prone
working conditions [44]. The situation in sub-Saharan
Africa is compounded by the shortage of human resources
for health, with nine physicians per 100,000 population and
55 nurses/midwives per 100,000 population: 64 HCPs
(physicians/nurses/midwives) per 100,000 population when
combined, which is far below the WHO target of at least
228 HCPs per 100,000 population [45]. Whereas healthcare
systems that create less tense or non-hostile working con-
ditions for HCPs might lower the incidence of harmful
MEs, reporting systems that foster confidentiality of
reported information and/or those that have an option for
anonymity of the ME reporter might encourage increased
participation of HCPs in healthcare quality improvement
and risk management systems [12]. It is worth noting,
however, that confidential ME reports seem to provide
higher quality information than anonymous ME reports
[13]. Healthcare professionals who agreed that the system
should report both actual and potential MEs were signifi-
cantly less likely to admit that they had committed harmful
MEs. Hesitancy might explain this finding given that dif-
fident ADR reporters [26] were also less likely to admit
Table 4 continued
Factor Ever made MEs with potential to
harm patients
Crude analysis Adjusted analysis
Agree (%) Other (%) OR 95 % CI P value OR 95 % CI P value
There is a lack of time for reporting MEs
Other 165 (16.9) 814 (83.1) 1.0 1.0
Agree 70 (21.2) 261 (78.8) 1.3 0.97–1.81 0.079 1.2 0.89–1.72 0.214
There is a culture of blame within healthcare
Other 79 (15.3) 438 (84.7) 1.0 1.0
Agree 156 (19.7) 637 (80.3) 1.4 1.01–1.83 0.043 1.2 0.87–1.66 0.269
There is a need for organizational leadership and support in reporting MEs
Other 42 (17.0) 205 (83.0) 1.0 1.0
Agree 193 (18.2) 870 (81.8) 1.1 0.75–1.56 0.671 1.1 0.72–1.71 0.637
System should report both actual and potential MEs
Other 91 (22.0) 322 (78.0) 1.0 1.0
Agree 144 (16.1) 753 (83.9) 0.7 0.50–0.91 0.009 0.6 0.44–0.85 0.003
I am more likely to make MEs in tense or hostile situations
Other 105 (13.1) 694 (86.9) 1.0 1.0
Agree 130 (25.4) 381 (74.6) 2.3 1.69–3.00 \0.001 2.0 1.47–2.77 \0.001
Important issues are well communicated at shift changes
Other 97 (21.5) 354 (78.5) 1.0 1.0
Agree 138 (16.1) 721 (83.9) 0.7 0.52–0.93 0.015 0.8 0.56–1.05 0.096
I may hesitate to use a reporting system for MEs because I am concerned about being identified
Other 130 (14.8) 748 (85.2) 1.0 1.0
Agree 105 (24.3) 327 (75.7) 1.8 1.39–2.46 \0.001 1.6 1.14–2.14 0.005
I should be financially rewarded for reporting MEs
Other 166 (17.1) 803 (82.9) 1.0 1.0
Agree 69 (20.2) 272 (79.8) 1.2 0.90–1.68 0.199 1.3 0.92–1.80 0.137
ADR adverse drug reaction
a The missing-assigned approach (missing data assigned to the ‘‘no’’ category) was used to account for missing data prior to commencing the
model fitting procedures
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Table 5 Characteristics of 1323a healthcare professional (HCPs) who ever identified potentially harmful medication errors (MEs) committed by
their colleagues, Uganda, 2013
Factor Ever identified potentially
harmful MEs made by others
Crude analysis Adjusted analysis
Agree (%) Other (%) OR 95 % CI P value OR 95 % CI P value
Level of health facility
Other 156 (31.5) 340 (68.5) 1.0 1.0
Hospital 386 (46.7) 441 (53.3) 1.9 1.51–2.41 \0.001 1.7 1.23–2.30 0.001
Type of health facility
Public 257 (45.9) 303 (54.1) 1.0 1.0
Private not-for-profit 115 (42.1) 158 (57.9) 0.9 0.64–1.15 0.305 0.9 0.66–1.26 0.573
Private for-profit 170 (34.7) 320 (65.3) 0.6 0.49–0.80 \0.001 0.9 0.68–1.32 0.751
Region of the country
Central 275 (45.5) 330 (54.5) 1.0 1.0
Eastern 141 (34.1) 272 (65.9) 0.6 0.48–0.81 \0.001 1.1 0.82–1.54 0.453
Other 126 (41.3) 179 (58.7) 0.8 0.64–1.12 0.235 1.2 0.89–1.67 0.221
Professional cadre
Nurse 268 (34.5) 509 (65.5) 1.0 1.0
Non-nurse 274 (50.2) 272 (49.8) 1.9 1.53–2.39 \0.001 1.5 1.15–1.92 0.002
Age (years)
Less than 30 245 (42.2) 336 (57.8) 1.0 1.0
30 or more 297 (40.0) 445 (60.0) 0.9 0.73–1.14 0.432 0.8 0.64–1.04 0.095
Department
Medicine 255 (39.4) 392 (60.6) 1.0
Surgery 40 (39.2) 62 (60.8) 1.0 0.65–1.52 0.970 0.8 0.49–1.25 0.302
Pediatrics, obstetrics and gynecology 79 (39.7) 120 (60.3) 1.0 0.73–1.40 0.942 0.8 0.57–1.16 0.247
Other 168 (44.8) 207 (55.2) 1.2 0.96–1.61 0.092 1.1 0.84–1.48 0.450
Patient load
More than 30/day 254 (42.9) 338 (57.1) 1.0 1.0
At most 30/day 288 (39.4) 443 (60.6) 0.9 0.69–1.08 0.197 0.9 0.70–1.14 0.350
Involved in medical research
No 360 (38.5) 574 (61.5) 1.0
Yes 182 (46.8) 207 (53.2) 1.4 1.10–1.78 0.006 1.3 1.02–1.71 0.034
Ever encountered fatal ADR
No 401 (37.7) 663 (62.3) 1.0 1.0
Yes 141 (54.4) 118 (45.6) 2.0 1.50–2.60 \0.001 1.5 1.13–2.05 0.006
Knows to whom to report ADRs
No 280 (42.4) 381 (57.6) 1.0 1.0
Yes 262 (39.6) 400 (60.4) 0.9 0.72–1.11 0.303 0.9 0.73–1.18 0.541
Suggested ways to improve ADR reporting
No 145 (43.8) 186 (56.2) 1.0 1.0
Yes 397 (40.0) 595 (60.0) 0.9 0.67–1.10 0.225 0.8 0.62–1.07 0.144
I would only report an ADR if I was sure that it was related to the use of a particular drug
Other 197 (39.7) 299 (60.3) 1.0 1.0
Agree 345 (41.7) 482 (58.3) 1.1 0.87–1.36 0.474 1.1 0.84–1.36 0.586
I do not know how information reported in an ADR form is used
Other 293 (39.9) 441 (60.1) 1.0 1.0
Agree 249 (42.3) 340 (57.7) 1.1 0.88–1.37 0.386 1.0 0.82–1.32 0.719
Root-cause analysis of MEs
Other 71 (34.6) 134 (65.4) 1.0 1.0
Agree 471 (42.1) 647 (57.9) 1.4 1.01–1.88 0.045 1.1 0.75–1.51 0.717
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that they had committed MEs that were potentially harmful
to patients.
Respondent HCPs who acknowledged that they had ever
seen others commit potentially harmful MEs were more
likely to be non-nurses or to have ever encountered a fatal
ADR. At the organizational level, they were more likely to
be attached to hospital-level health facilities, to have cited
that there exists a blame culture in healthcare, or to have
reported working in stressful working conditions. Organi-
zational-level factors have been reported to dominate over
individual-level factors as major contributors to the
occurrence of MEs [46]. Rather than blame or penalize
individual HCPs, employing a ‘‘no-blame’’ systems
approach could reduce the incidence of MEs and stimulate
HCPs’ participation in ME reporting initiatives [29], hence
promoting delivery of safer healthcare to Ugandan patients.
This study had limitations. First, HCPs may have pro-
vided socially desirable responses on sensitive questions
such as being less likely to disclose that they had ever
committed potentially harmful MEs. Since we used
anonymous self-administered questionnaires, this bias
might have been diminished. Second, some variables
measured similar attitudinal constructs and may have pre-
sented challenges of multiplicity during data analysis;
however, we did not fit logically similar variables into the
same regression models, and we focused attention only on
influential factors for which P\ 0.01. In addition, factor
analysis and principal components analysis techniques
were employed to identify any groups of variables that
could be combined into single factors or components,
respectively, although none were identified. Third, proba-
bility sampling was not practicable; however, the large
sample size is a key strength of this study. Fourth, we did
not pose open-ended questions or conduct qualitative
interviews to triangulate these research findings. Accepting
the invitation to complete an anonymous self-administered
questionnaire was received with much apprehension,
especially when potential respondent HCPs noticed the
Table 5 continued
Factor Ever identified potentially
harmful MEs made by others
Crude analysis Adjusted analysis
Agree (%) Other (%) OR 95 % CI P value OR 95 % CI P value
There is a lack of time for reporting MEs
Other 399 (40.3) 591 (59.7) 1.0 1.0
Agree 143 (42.9) 190 (57.1) 1.1 0.87–1.43 0.397 1.1 0.85–1.46 0.446
There is a culture of blame within healthcare
Other 164 (31.4) 358 (68.6) 1.0 1.0
Agree 378 (47.2) 423 (52.8) 2.0 1.55–2.46 \0.001 1.6 1.28–2.11 \0.001
There is a need for organizational leadership and support in reporting MEs
Other 74 (29.5) 177 (70.5) 1.0 1.0
Agree 468 (43.7) 604 (56.3) 1.9 1.38–2.49 \0.001 1.3 0.91–1.81 0.147
System should report both actual and potential MEs
Other 148 (35.2) 272 (64.8) 1.0 1.0
Agree 394 (43.6) 509 (56.4) 1.4 1.12–1.81 0.004 1.2 0.89–1.52 0.257
I am more likely to make MEs in tense or hostile situations
Other 283 (35.1) 524 (64.9) 1.0 1.0
Agree 259 (50.2) 257 (49.8) 1.9 1.49–2.34 \0.001 1.4 1.12–1.84 0.005
Important issues are well communicated at shift changes
Other 184 (39.9) 277 (60.1) 1.0 1.0
Agree 358 (41.5) 504 (58.5) 1.1 0.85–1.35 0.569 1.1 0.88–1.47 0.309
I may hesitate to use a reporting system for MEs because I am concerned about being identified
Other 335 (37.6) 557 (62.4) 1.0 1.0
Agree 207 (48.0) 224 (52.0) 1.5 1.22–1.94 \0.001 1.3 0.97–1.61 0.084
I should be financially rewarded for reporting MEs
Other 383 (39.2) 594 (60.8) 1.0 1.0
Agree 159 (46.0) 187 (54.0) 1.3 1.03–1.69 0.028 1.3 0.99–1.69 0.061
ADR adverse drug reaction
a The missing-assigned approach (missing data assigned to the ‘‘no’’ category) was used to account for missing data prior to commencing the
model fitting procedures
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section on MEs. Due to the sensitivity of this subject, and
to encourage HCPs’ participation in this survey, we
structured the MEs section to contain only closed-ended
questions. However, we believe that the results of this
study have generated hypotheses that can be investigated
further using different or similar methods of inquiry.
5 Conclusions
Most Ugandan HCPs approved the establishment of a
national ME reporting system. However, as the program is
implemented, sensitization and training of HCPs on how to
identify and report MEs will be necessary. A non-punitive
healthcare environment and patient involvement may pro-
mote ME disclosure and reporting in Uganda and possibly
other African countries.
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